After much angst and drama, the real work on health care reform now begins
The political theater that was made by the year-long health care reform debate will now be followed by months, if not years of action (or inaction) to bring the plan to reality of the lives of Americans. This we know, the final chapter of this sweeping change in national social policy has not been written. More than 30 million on the uninsured will get health benefits, but time will tell if they are satisfied with the product and if taxpayers are getting a fair break on the investment of these dollars from the public troth. All members of the current congress will be retired or voted out of office by the time we learn the benefits and the negatives of this legislation.
Now that the historic health care reform plan passed in the House in a rare all-day Sunday session, March 21, the full impact of the bill will not be known for years. And that proposition assumes that the bill survives the legal challenges now threatened by opposition both in Washington and beyond. So that’s one thing that hasn’t changed: The litigious nature of our society provides a perverse counterpoint to almost every action by lawmakers.
WASHINGTON – It’s not just change to believe in – it’s change that’s real after the U.S. House of Representatives voted Sunday night for a sweeping overhaul of American health care.
Bone marrow transplants, aka stem cell transplants (SCT) offer a second chance for people with life-threatening blood cancers and other hematologic malignancies. I know because I am one of the SCT success stories from the place known as City of Hope (COH).▶ COH performed its first bone marrow transplant in 1976. Since then, thousands of patients from virtually every state and dozens of countries have undergone bone marrow, cord blood or stem cell transplants at COH.▶ Hematopoietic stem cell transplantation (HSCT) is the transplantation of multipotent hematopoietic stem cells, usually derived from bone marrow, peripheral blood, or umbilical cord blood.▶ It may be autologous (the patient's own stem cells are used), allogeneic (the stem cells come from a donor) or syngeneic (from an identical twin).▶ It is a medical procedure in the field of hematology, most often performed for patients with certain cancers of the blood or bone marrow, such as multiple myeloma, lymphoma (my DX) or …
▶ Gradually, but surely, we are now archiving MyJournal posts in our G+ collection. Follow us there.
▶ First day of the winter solstice arrived yesterday and that generally means no real change in the weather conditions for Southern California, but we have finally had a few days of partly-cloudy rain to initiate the official changing of the seasons▶ Unfortunately and personally, the last few months have been mostly marked with prolonged and unrelenting respiratory distress, officially diagnosed last Friday as acute bronchitis.
▶ A new cocktail of medicines have been prescribed: 1) Ibratropium Bromide nasal spray; 2) Prednisone, a steroid; and 3) Benzonatate, a cough suppressant. All of this followed my third IVIG in three months since September at City of Hope, as that last procedure generally lasts me for six months, but not at this time. Immune system issues remain and underlying challenge in my ninth year post DX with mantle cell lymphoma and eight years post the allogeneic stem ce…
ACOR▶ a large collection of cancer-related online email lists, which has delivered millions of email messages to subscribers across the globe. https://goo.gl/mjrQ77
An INTRANET is a private network accessible only to an organization's staff or members. Generally a wide range of information and services from the organization's internal IT systems are available that would not be available to the public from the Internet. By function, ACORis an INTRANETsite.
When a #Canswerist (aka cancer survivor or caregiver) looks to begin or extend research for their diagnosis (DX), the world wide web (or internet) is a logical starting points. Typically, such a search may lead to discovery on a range of INTRANETS.